Retrospective study evaluating safety, clinical effect, and dosing of dalteparin for the treatment of venous thromboembolism in term neonates.

Nancy ShermanMuhammad YounusKevin WolterSuresh VictorVenkatesh KairamkondaEleri AdamsHelen BrothertonElaine M Boyle

Published in: Pediatric blood & cancer (2024)

Dalteparin treatment in neonates raised no major safety concerns. Larger cohort studies may help provide further insights on clinical effects of dalteparin for neonatal VTE.

Keyphrases

venous thromboembolism
preterm infants
low birth weight
direct oral anticoagulants
combination therapy
atrial fibrillation
gestational age
smoking cessation